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biomaterials and devicesThe applications of orthopaedic biomaterials, implants and
devices are to stabilize, improve, protect, replace, or
regenerate damaged musculoskeletal tissues both
anatomically and functionally. For example: the use of
permanent implants in arthroplasty, trauma, spine and
tumour surgeries; the use of degradable biomaterials and
tissue engineered constructs to substitute, conduct or
induce tissue repair or regeneration; and the use of support
devices as exoskeletons. Though biocompatibility and me-
chanical compatibility are still the primary requirements
for medical implants and devices, research on how to
improve the bioactivity of implanted materials over time
has become the major focus of biomaterial research in the
last decade. Recently, ideas on designing third-generation
materials that stimulate specific responses in surrounding
tissues at the molecular level have been proposed [1]. This
special issue of the Journal of Orthopaedic Translation
presents eight articles that introduce the latest advances
and applications of orthopaedic biomaterials and devices.
Bioactive and biodegradable implants
Titanium and titanium alloy based biomaterials have been
widely used to fabricate orthopaedic implants due to their
good mechanical properties and biocompatibility. Consid-
ering the bio-inert nature of titanium, various materials
have been coated onto the surface of the implants to
improve their bioactivity [2,3]. In this issue of the journal,
Ao et al reports a new approach to biochemically modifyinghttp://dx.doi.org/10.1016/j.jot.2016.02.001
2214-031X/Copyright ª 2016, The Authors. Published by Elsevier (Singap
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).the surface of titanium implants in order to improve the
activity of mesenchymal stem cells [4]. They demonstrated
that type I collagen that has been covalently immobilized
onto the titanium coating promotes the migration of stem
cells into the porous structure of the implant in vitro and
enhances the osteointegration of implants in vivo. This type
of coating with biologic macromolecules may be further
combined with growth factors or antibacterial agents to
promote implant fixation with biological functions or to
combat implant-associated infections [5,6]. This approach
has become a hot topic in the R&D of innovative
biomaterials.
Biodegradable magnesium-based metal implants are a
revolutionary metallic material. However, some challenges
still remain, such as the rapid corrosion rate and its asso-
ciated challenges with regards to its biocompatibility [7,8].
One of the major concerns is the formation of hydrogen gas
cavities during in vivo degradation of magnesium implants.
Noviana et al investigated the effect of hydrogen gas on rat
mortality and found that gas cavities were rapidly formed
around the site of implantation and subsequently
decreased the survival rate of the rats [9]. The production
of hydrogen gas may depend on the degradation rate of
magnesium implants and varies in different microenviron-
ments. More R&D efforts and related studies are desirable
to address this problem.
Materials or allograft to promote tissue
regeneration
The main function of tissue-repairing materials is to serve
as a scaffold to promote the differentiation of osteogenic
cells and vascularization. Enhanced osteogenesis can be
achieved by loading growth factors and stem cells within
scaffolds, or constructing tissue-engineered bone. Petta
et al report on the preparation of a new composite of b-
tricalcium phosphate and a thermoresponsive hyaluronan
hydrogel, which can be used in the form of injectable or
moldable paste [10]. Owing to its amphiphilicore) Pte Ltd. This is an open access article under the CC BY-NC-ND
70 Editorialcharacteristic, this composite can be supplemented with
small hydrophobic molecules or biologics, for example to
provide controlled release of both rhBMP-2 and dexa-
methasone for improved osteoinductivity. Similar efforts
have been made by Ding’s group, who developed and tested
bone graft materials in a novel perfusion bioreactor to
promote bone formation [11].
Compared to partial bone and cartilage defects, the
treatment of full-thickness osteochondral injury is more
challenging. In a recent study, a goat femoral head was
successfully regenerated using a tissue-specific biphasic
scaffold fabricated with CAD/CAM and 3D printing technol-
ogy [12]. It is a promising approach to regenerating a bio-
logical joint, but whether it can become a cost-effective
approach that can replace osteochondral allograft trans-
plantationda well-accepted surgical treatmentdremains
for further investigation. The objective of Crist et al’s study
presented in this issue of the journal was to compare
femoral head osteochondral autografts and allografts in a
canine model [13]. The authors reported that there was a
significant loss in range of motion, chondrocyte viability and
articular cartilage integrity 8 weeks after implantation of
both small autografts and allografts, whereas chondrocytes
in the large allografts maintained their viability and struc-
tural integrity throughout the study period. A similar type of
large allograft (> 30 mm) was implanted into four human
patients. After 4e18 months of follow-up, all patients could
withstand full weight-bearing and showed no evidence of
graft failure or progressive arthrosis, implying the trans-
lational potential of their proof-of-concept research.
Another report is on intervertebral disc disease. Stan-
nard et al developed a whole organ culture model of
intervertebral discs in a rotating wall vessel bioreactor [14].
The annulus fibrosus was penetrated with a 20G needle to
the nucleus pulposus and aspirated, which produced path-
ologic changes consistent with those observed in degener-
ative intervertebral disc disease in humans. Compared with
animal models that are often time-consuming and high
cost, this in vitro model provides a convenient way to
investigate new treatment approaches, including various
tissue engineering strategies [15].
Robotic devices
Recently, the demand for robotic devices has increased
significantly, driven by the rapid growth of an aging popu-
lation and increase in mobility disorders globally. Ad-
vancements in biomedical engineering, computer science
and medical imaging technology have brought about a
revolution in robotic devices [16,17]. The review in this
issue of the journal by Chen et al introduces the general
concept of exoskeletons and several typical lower ex-
tremity exoskeletons (LEEs) in gait rehabilitation, human
locomotion assistance and human strength augmentation
[18]. The limitations of current LEEs and their future
research and development are discussed. The paper by Qin
et al introduces the housing design and testing of a surgical
robot [19]. Based on the general requirements for Class II
Medical Devices, a modern surgical robot was designed and
approved for use in orthopaedic surgeries in Hong Kong.
This project demonstrated the successful collaboration inthe multidisciplinary R&D led by orthopaedic surgeons
together with mechanical and electronic engineers and
industrial designers.
Limited by the issue’s volume, we cannot include all of
the hot topics in the research of orthopaedic biomaterials,
implants and devices, such as innovations in nano-
biomaterials, drug delivery systems [20] and 3D printing
technology [21,22]. Although great progress has been made
in recent years, success in translating orthopaedic bio-
materials, implants and devices into clinical applications
(or from bench to bedside) remains a challenge. Further
improvements in the current academic or professional
promotion systems, close collaboration among scientists,
engineers, clinicians and industrial partners, and efficient
communication between investigators and government
regulators are key issues that need to be addressed to
promote future translational studies.
Finally, we wish to reemphasize the relevant issues
raised in the Editorial of the inaugural issue of the Journal
of Orthopaedic Translation [23] with regard to scientific
reports of R&D of biomaterials or implants/devices.
Essential information on the testing or evaluation methods
should be provided whenever possible and follow the rec-
ommended tests listed by the ISO and/or American Society
for Testing Materials (ASTM). This approach will help our
R&D work to be appreciated by the regulatory bodies or
certified testing centres of the Food and Drug Administra-
tion in the United States or the China Food and Drug
Administration (CFDA) in China, which in turn will help
shorten the regulatory registration process. Apart from
testing the efficacy and safety of these products, their cost-
effectiveness should also be addressed for product regis-
tration. Finally, clinical trials should be conducted to
collect important information for building up a solid foun-
dation for their long-term sustainable development and
clinical translation.References
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